Pets
“A controlled, peer-reviewed study published in Frontiers in Veterinary Science found that dogs fed freeze-dried shiitake mushroom powder for 4 weeks showed an 85% boost in expression of SIRT1, a gene associated with healthy aging." (Post images add: "DOGS FED COMMON GROCERY STORE MUSHROOMS FOR JUST 4 WEEKS: 85% BOOST IN THE EXPRESSION OF…”
Plain restatementA peer-reviewed paper in Frontiers in Veterinary Science (DOI 10.3389/fvets.2024.1355560) reports that dogs given shiitake mushroom powder for four weeks had higher leukocyte SIRT1 mRNA expression (about 85% above their own baseline) and higher plasma superoxide dismutase activity (about 410% above baseline), and the post presents these as evidence that grocery-store mushrooms support healthy aging in dogs.
General information only - not veterinary advice.
The study behind this post is real. Kusaba and Arai published it in Frontiers in Veterinary Science in 2024, and the 85% and 410% figures do match the numbers printed in its tables. The problems are in how it is described. Only eight Beagles took part, four fed shiitake powder and four fed nothing, and the paper states that no placebo group was used because there were too few animals, calls itself preliminary, and compares each group only against its own starting values. The untreated control dogs' SIRT1 numbers also went up over the same four weeks. The dogs received a concentrated powder at 800 mg per kg of body weight every day, which is about 3.6 grams daily for a 10 lb dog and about 25 grams for a 70 lb dog, not a few sautéed mushrooms at dinner, and the paper says the right dose for dogs was not worked out. Nothing in the study measured whether any dog lived longer or stayed healthier, and the amounts the post lists for feeding come from lower-dose work, not from the trial that produced the headline numbers. General information only, not veterinary advice.
A [drifted from the evidence:] controlled, peer-reviewed [drifted from the evidence:] study published in Frontiers in Veterinary Science [drifted from the evidence:] found that dogs [drifted from the evidence:] fed freeze-dried shiitake mushroom powder for [drifted from the evidence:] 4 weeks [drifted from the evidence:] showed an 85% boost in expression of SIRT1, [drifted from the evidence:] a gene associated with healthy aging." (Post images add: "DOGS FED COMMON GROCERY STORE MUSHROOMS FOR JUST 4 WEEKS: 85% [drifted from the evidence:] BOOST IN THE [drifted from the evidence:] EXPRESSION OF A GENE THAT [drifted from the evidence:] CAN HELP DOGS LIVE LONGER. 410% BOOST IN [drifted from the evidence:] ENZYME ACTIVITY THAT PROTECTS THEIR CELLS FROM DAMAGE!")
A peer-reviewed [added by the neutral restatement:] paper in Frontiers in Veterinary Science [added by the neutral restatement:] (DOI 10.3389/fvets.2024.1355560) reports that dogs [added by the neutral restatement:] given shiitake mushroom powder for [added by the neutral restatement:] four weeks [added by the neutral restatement:] had higher leukocyte SIRT1 [added by the neutral restatement:] mRNA expression (about 85% [added by the neutral restatement:] above their own baseline) and higher plasma superoxide dismutase activity (about 410% above baseline), and the [added by the neutral restatement:] post presents these as evidence that [added by the neutral restatement:] grocery-store mushrooms support healthy aging in [added by the neutral restatement:] dogs.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- The paper is real, peer-reviewed, and published in Frontiers in Veterinary Science in 2024 under the DOI given in the post (10.3389/fvets.2024.1355560).
- Dogs in the study were fed shiitake powder for four weeks, as the post says.
- The 85% figure matches the published group means for leukocyte sirtuin1 mRNA in the four supplemented dogs (0.13 to 0.24, normalised to beta-actin), and the paper reports that rise as statistically significant against those same dogs' week 0 values.
- The 410% figure matches the published plasma SOD means in those same four dogs (20.2 to 103.0 U/mL), which the paper's text describes as an increase to five times.
- Total cholesterol fell significantly in the supplemented dogs in this study, which supports the post's secondary statement that canine data point to effects on cholesterol.
- SIRT1 is genuinely a gene studied in the biology of aging, and the paper itself frames the finding around age-related disease.
- The post's warning never to let a dog forage wild mushrooms, and to seek emergency veterinary care if one is eaten, is consistent with veterinary toxicology guidance.
- The post calls the study "controlled." The paper states that no placebo group was set because there were not enough animals, and the significance asterisks mark each group against its own week 0 values rather than against the control group. The four untreated control dogs' sirtuin1 mean also rose over the same four weeks (0.07 to 0.13), a similar proportional change, and their SOD mean rose too (22.7 to 38.0). A reader told the study was "controlled" would reasonably assume the 85% was measured against a comparison group. It was not. (Omitted qualifier, exaggeration.)
- The headline "DOGS FED..." presents a result from four young healthy laboratory Beagles as a general finding about dogs. The paper calls itself preliminary and lists small sample size and uncontrolled age and sex as limitations. (Subgroup generalization.)
- The image says SIRT1 is "a gene that can help dogs live longer." Nothing in this study measured lifespan, illness or any health outcome. It measured mRNA in white blood cells and enzyme activity in plasma over four weeks. Separate canine work on SIRT1 notes that a link between raised SIRT1 expression and lifespan extension has not been fully demonstrated, and that expression varies markedly between individual dogs. (Causal overreach, temporal overreach.)
- The image frames this as "common grocery store mushrooms." The study fed a concentrated dried powder supplied by a mushroom company at 800 mg/kg body weight per day. That is roughly 3.6 g of powder daily for a 10 lb dog and about 25 g daily for a 70 lb dog, every day for four weeks. Sautéed or broth-prepared culinary mushrooms at mealtime are not the tested intervention. (Omitted qualifier.)
- The feeding amounts listed in the caption are attributed to "separate, lower-dose studies on cholesterol," which is a lower exposure than the 800 mg/kg/day at which the 85% and 410% figures were recorded. Placing those amounts under the headline numbers invites a reader to connect the two. The paper states explicitly that the optimal dose for dogs was not examined, and the earlier preprint reports the significant cholesterol fall in the high dose group. (Dose omitted.)
- The 85% and 410% percentages do not appear in the paper. They are calculated by the post from the group means. The arithmetic is right, but percentage change computed from four animals with the reported spread (control sirtuin1 0.13 plus or minus 0.09) conveys a precision the data do not carry. (Exaggeration.)
- Whether the sirtuin1 rise in the supplemented dogs is distinguishable from the rise seen in the untreated controls cannot be determined from the published report, because no between-group test is reported.
- Whether any of these biomarker changes translate into a health benefit, a reduction in age-related disease, or a longer life in dogs is untested. No study located measures those outcomes for shiitake in dogs.
- Whether lower amounts, such as those listed in the post, move SIRT1 or SOD at all is unknown. The 100 mg/kg/day arm appears only in a preprint, and the published paper says the optimal dose was not examined.
- Whether cooked culinary shiitake served as a meal topper delivers comparable eritadenine or other active components to the tested dried powder was not studied.
- The canine SIRT1 and SOD findings come from a single research group. No independent replication in dogs was located.
- The secondary statement that "additional canine studies" support fat metabolism and cholesterol balance rests, as far as could be traced, on the same group's work including a non-peer-reviewed preprint, not on a separate independent body of canine research.
The study exists, the journal and DOI are correct, and the two headline numbers are arithmetically consistent with the published group means. Design: eight healthy Beagles, four males and four females, aged 1 to 3 years. Four dogs received shiitake powder at 800 mg/kg body weight per day for four weeks. The other four received nothing and served as untreated controls. The paper states plainly: "The placebo group for shiitake powder was not set because the number of animals was not enough," and describes itself as preliminary, with limitations including small sample size and uncontrolled age and sex variation. It also states that the optimal dose for dogs was not examined. Statistics: a paired t-test, with asterisks marking values "significantly different (p < 0.05) from the values at week 0 in the own group." The published results are within-group before-and-after comparisons. No between-group statistical comparison of supplemented versus control dogs is reported. Results in the supplemented dogs: leukocyte sirtuin1 mRNA normalised to beta-actin rose from 0.13 to 0.24 (an 85% rise), and plasma SOD activity rose from 20.2 to 103.0 U/mL (a 410% rise, described in the text as "increased to five times"). Plasma total cholesterol fell from 128 to 91 mg/100 mL. Body weight, body condition score, glucose, triglycerides, insulin, ALT and AST did not change. Results in the untreated control dogs, as printed in the same tables: sirtuin1 mRNA 0.07 to 0.13, and SOD 22.7 to 38.0 U/mL. Neither carries a significance asterisk, but the control group's sirtuin1 mean rose by a similar proportion over the same four weeks. Test article and funding: the powder was prepared and supplied by Mori & Company, Ltd. (a mushroom company). The authors declare that no financial support was received and that there was no commercial or financial relationship constituting a conflict of interest. Narita Animal Science Laboratory monitored the animals. Related canine data: an earlier preprint from the same group tested 800 mg/kg/day and 100 mg/kg/day for four weeks and reports that total cholesterol fell significantly in the high dose group. That preprint is not peer-reviewed in the version located.
Complete reasoning
The reply is formatted for pasting into the thread where the claim is circulating.
Ask this case
Answers come only from the case file above; nothing is added.
Is the study behind this claim real?
Yes. It is a peer-reviewed paper by Kusaba and Arai published in Frontiers in Veterinary Science in 2024, and the DOI matches. The 85% and 410% figures are consistent with the numbers in the paper's tables.
Was this a controlled study, as the post claims?
Not in the way the word implies. The paper states no placebo group was used because there were too few animals, and the reported significance only compares each group to its own starting values, not supplemented dogs against untreated ones. The untreated control dogs also showed increases in the same markers over the same four weeks.
Does this mean grocery store mushrooms can help dogs live longer?
The study did not measure lifespan or any health outcome at all. It measured gene expression in blood cells and an enzyme's activity in plasma over four weeks in eight young Beagles, and the paper itself calls the findings preliminary.
Were the dogs eating the same mushrooms you'd buy at a grocery store?
No. They received a concentrated freeze-dried powder supplied by a mushroom company at a dose of 800 mg per kg of body weight daily, which works out to several grams a day depending on the dog's size. This is not the same as feeding a dog a few cooked mushrooms.
Did the study find any other effects, like on cholesterol?
Yes, total cholesterol dropped significantly in the supplemented dogs. Other measures, including body weight, glucose, and liver enzymes, showed no change.